Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
BMC Public Health ; 21(1): 2002, 2021 11 04.
Artigo em Inglês | MEDLINE | ID: mdl-34736425

RESUMO

BACKGROUND: We analyzed the association between substance use (SU) and condomless sex (CS) among HIV-negative adults reporting heterosexual sex in the Seek, Test, Treat, and Retain (STTR) consortium. We describe the impact of SU as well as person/partner and context-related factors on CS, identifying combinations of factors that indicate the highest likelihood of CS. METHODS: We analyzed data from four US-based STTR studies to examine the effect of SU on CS using two SU exposures: 1) recent SU (within 3 months) and 2) SU before/during sex. Behavioral data were collected via 1:1 or self-administered computerized interviews. Adjusted individual-study, multivariable relative risk regression was used to examine the relationship between CS and SU. We also examined interactions with type of sex and partner HIV status. Pooled effect estimates were calculated using traditional fixed-effects meta-analysis. We analyzed data for recent SU (n = 6781; 82% men, median age = 33 years) and SU before/during sex (n = 2915; 69% men, median age = 40 years). RESULTS: For both exposure classifications, any SU other than cannabis increased the likelihood of CS relative to non-SU (8-16%, p-values< 0.001). In the recent SU group, however, polysubstance use did not increase the likelihood of CS compared to single-substance use. Cannabis use did not increase the likelihood of CS, regardless of frequency of use. Type of sex was associated with CS; those reporting vaginal and anal sex had a higher likelihood of CS compared to vaginal sex only for both exposure classifications (18-21%, p < 0.001). Recent SU increased likelihood of CS among those reporting vaginal sex only (9-10%, p < 0.001); results were similar for those reporting vaginal and anal sex (5-8%, p < 0.01). SU before/during sex increased the likelihood of CS among those reporting vaginal sex only (20%; p < 0.001) and among those reporting vaginal and anal sex (7%; p = 0.002). Single- and poly-SU before/during sex increased the likelihood of CS for those with exclusively HIV-negative partners (7-8%, p ≤ 0.02), and for those reporting HIV-negative and HIV-status unknown partners (9-13%, p ≤ 0.03). CONCLUSION: Except for cannabis, any SU increased the likelihood of CS. CS was associated with having perceived HIV-negative partners and with having had both anal/vaginal sex.


Assuntos
Infecções por HIV , Transtornos Relacionados ao Uso de Substâncias , Adulto , Preservativos , Feminino , Infecções por HIV/epidemiologia , Heterossexualidade , Homossexualidade Masculina , Humanos , Masculino , Assunção de Riscos , Comportamento Sexual , Parceiros Sexuais , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Sexo sem Proteção
2.
AIDS Behav ; 24(2): 475-483, 2020 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-31049808

RESUMO

More than 10 years after the Centers for Disease Control and Prevention recommended routine HIV testing for patients in emergency departments (ED) and other clinical settings, as many as three out of four patients may not be offered testing, and those who are offered testing frequently decline. The current study examines how participant characteristics, including demographics and reported substance use, influence the efficacy of a video-based intervention designed to increase HIV testing among ED patients who initially declined tests offered by hospital staff. Data from three separate trials in a high volume New York City ED were merged to determine whether patients (N = 560) were more likely to test post-intervention if: (1) they resembled people who appeared onscreen in terms of gender or race; or (2) they reported problem substance use. Chi Square and logistic regression analyses indicated demographic concordance did not significantly increase likelihood of accepting an HIV test. However, participants who reported problem substance use (n = 231) were significantly more likely to test for HIV in comparison to participants who reported either no problem substance use (n = 190) or no substance use at all (n = 125) (x2 = 6.830, p < 0.05). Specifically, 36.4% of patients who reported problem substance use tested for HIV post-intervention compared to 30.5% of patients who did not report problem substance use and 28.8% of participants who did not report substance use at all. This may be an important finding because substance use, including heavy alcohol or cannabis use, can lead to behaviors that increase HIV risk, such as sex with multiple partners or decreased condom use.


Assuntos
Sorodiagnóstico da AIDS/estatística & dados numéricos , Computadores , Serviço Hospitalar de Emergência/estatística & dados numéricos , Infecções por HIV/diagnóstico , Programas de Rastreamento/métodos , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Cooperação do Paciente/estatística & dados numéricos , Gravação em Vídeo , Sorodiagnóstico da AIDS/métodos , Adolescente , Adulto , Centers for Disease Control and Prevention, U.S. , Testes Diagnósticos de Rotina , Feminino , Infecções por HIV/prevenção & controle , Humanos , Masculino , Pessoa de Meia-Idade , New York/epidemiologia , Cidade de Nova Iorque , Aceitação pelo Paciente de Cuidados de Saúde/psicologia , Cooperação do Paciente/psicologia , Educação de Pacientes como Assunto , Testes Sorológicos , Parceiros Sexuais , Transtornos Relacionados ao Uso de Substâncias , Estados Unidos
3.
Lymphology ; 46(2): 85-96, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24354107

RESUMO

Advances in bioelectrical impedance analysis (BIA) permit the assessment of lymphedema by directly measuring lymph fluid changes. The objective of the study was to examine the reliability, sensitivity, and specificity of cross-sectional assessment of BIA in detecting lymphedema in a large metropolitan clinical setting. BIA was used to measure lymph fluid changes. Limb volume by sequential circumferential tape measurement was used to validate the presence of lymphedema. Data were collected from 250 women, including healthy female adults, breast cancer survivors with lymphedema, and those at risk for lymphedema. Reliability, sensitivity, specificity and area under the ROC curve were estimated. BIA ratio, as indicated by L-Dex ratio, was highly reliable among healthy women (ICC=0.99; 95% CI = 0.99 - 0.99), survivors at-risk for lymphedema (ICC=0.99; 95% CI = 0.99 - 0.99), and all women (ICC=0.85; 95% CI = 0.81 - 0.87); reliability was acceptable for survivors with lymphedema (ICC=0.69; 95% CI = 0.54 to 0.80). The L-Dex ratio with a diagnostic cutoff of >+7.1 discriminated between at-risk breast cancer survivors and those with lymphedema with 80% sensitivity and 90% specificity (AUC=0.86). BIA ratio was significantly correlated with limb volume by sequential circumferential tape measurement. Cross-sectional assessment of BIA may have a role in clinical practice by adding confidence in detecting lymphedema. It is important to note that using a cutoff of L-Dex ratio >+7.1 still misses 20% of true lymphedema cases, it is important for clinicians to integrate other assessment methods (such as self-report, clinical observation, or perometry) to ensure the accurate detection of lymphedema.


Assuntos
Braço/patologia , Neoplasias da Mama/terapia , Impedância Elétrica , Linfedema/diagnóstico , Linfedema/etiologia , Índice de Massa Corporal , Estudos Cross-Over , Feminino , Humanos , Entrevistas como Assunto , Pessoa de Meia-Idade , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
4.
Health Educ Res ; 28(4): 574-90, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23669214

RESUMO

AIDS clinical trials (ACTs) are critical to the development of new treatments for HIV infection. However, people of color living with HIV/AIDS are involved in ACTs at disproportionally low rates, with African-Americans experiencing the greatest under-representation. In this article, we describe the core elements and key characteristics of a highly efficacious multi-component peer-driven intervention (PDI) designed to increase rates of screening for and enrollment into ACTs among African-American and Latino/Hispanic individuals, by addressing the main complex, multi-level barriers they experience to ACTs. We discuss the process of developing the intervention, the theoretical models guiding its delivery format and content, and provide an overview of the intervention's components. We then use brief case studies to illustrate a number of key issues that may arise during intervention implementation. Finally, we describe lessons learned and provide recommendations for the PDI's uptake in clinical and clinical trials settings.


Assuntos
Síndrome da Imunodeficiência Adquirida/tratamento farmacológico , Negro ou Afro-Americano/psicologia , Ensaios Clínicos como Assunto/psicologia , Conhecimentos, Atitudes e Prática em Saúde/etnologia , Hispânico ou Latino/psicologia , Seleção de Pacientes , Síndrome da Imunodeficiência Adquirida/diagnóstico , Síndrome da Imunodeficiência Adquirida/etnologia , Negro ou Afro-Americano/educação , Negro ou Afro-Americano/estatística & dados numéricos , Atitude do Pessoal de Saúde , Ensaios Clínicos como Assunto/normas , Ensaios Clínicos como Assunto/estatística & dados numéricos , Medo/psicologia , Feminino , Hispânico ou Latino/educação , Hispânico ou Latino/estatística & dados numéricos , Humanos , Masculino , Programas de Rastreamento/psicologia , Educação de Pacientes como Assunto/métodos , Navegação de Pacientes/métodos , Navegação de Pacientes/organização & administração , Grupo Associado , Viés de Seleção , Confiança/psicologia
5.
Lymphology ; 44(3): 134-43, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22165584

RESUMO

It has been speculated that symptomatic seroma, or seroma requiring needle aspiration, is one of the risk factors for lymphedema symptoms following breast cancer treatment. These symptoms exert tremendous impact on patients' quality of life and include arm swelling, chest/breast swelling, heaviness, tightness, firmness, pain, numbness, stiffness, or impaired limb mobility. Our aim was to explore if symptomatic seroma affects lymphedema symptoms following breast cancer treatment. Data were collected from 130 patients using a Demographic and Medical Information interview tool, Lymphedema and Breast Cancer Questionnaire, and review of medical record. Arm swelling was verified by Sequential Circumferential Arm Measurements and Bioelectrical Impedance Spectroscopy. Data analysis included descriptive statistics, Chi-squared tests, regression, exploratory factor analysis and exploratory structural equation modeling. Thirty-five patients (27%) developed symptomatic seroma. Locations of seroma included axilla, breast, and upper chest. Significantly, more women with seroma experienced more lymphedema symptoms. A well-fit exploratory structural equation model [X2(79) = 92.15, p = 0.148; CFI = 0.97; TLI = 0.96] revealed a significant unique effect of seroma on lymphedema symptoms of arm swelling, chest/breast swelling, tenderness, and blistering (beta = 0.48, p < 0.01). Patients who developed symptomatic seroma had 7.78 and 10.64 times the odds of developing arm swelling and chest/breast swelling versus those who did not, respectively (p < 0.001). Symptomatic seroma is associated with increased risk of developing lymphedema symptoms following breast cancer treatment. Patients who develop symptomatic seroma should be considered at higher risk for lymphedema symptoms and receive lymphedema risk reduction interventions.


Assuntos
Neoplasias da Mama/cirurgia , Linfedema/etiologia , Complicações Pós-Operatórias/etiologia , Seroma/complicações , Adulto , Idoso , Estudos Transversais , Feminino , Humanos , Pessoa de Meia-Idade
6.
Psychol Rep ; 87(1): 37-47, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11026388

RESUMO

A Monte Carlo evaluation of four procedures for detecting taxonicity was conducted using artificial data sets that were either taxonic or nontaxonic. The data sets were analyzed using two of Meehl's taxometric procedures, MAXCOV and MAMBAC, Ward's method for cluster analysis in concert with the cubic clustering criterion and a latent variable mixture modeling technique. Performance of the taxometric procedures and latent variable mixture modeling were clearly superior to that of cluster analysis in detecting taxonicity. Applied researchers are urged to select from the better procedures and to perform consistency tests.


Assuntos
Análise por Conglomerados , Modelos Estatísticos , Método de Monte Carlo , Psicometria/métodos , Interpretação Estatística de Dados , Humanos
7.
Subst Use Misuse ; 35(12-14): 1967-2009, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11138714

RESUMO

This study presents a review and meta-analyses of research on the recidivism-reducing impact of correctionally based treatment programs in Germany. The data are part of the Correctional Drug Abuse Treatment Effectiveness (CDATE) project meta-analytic database (covering 1968-1996) of evaluation research studies of correctional interventions. Overall, the five studies of educational programs show no practical impact of these programs in reducing recidivism. Four studies of programs to counsel driving-under-the-influence (DUI) offenders fall in an intermediate area (not statistically significant, but promising enough to warrant further research). The eight studies of Social Therapy programs did show, on the average, a statistically significant practical impact in reducing recidivism.


Assuntos
Alcoolismo/reabilitação , Avaliação de Processos e Resultados em Cuidados de Saúde , Prisões , Garantia da Qualidade dos Cuidados de Saúde , Transtornos Relacionados ao Uso de Substâncias/reabilitação , Crime/prevenção & controle , Seguimentos , Alemanha , Pesquisa sobre Serviços de Saúde , Humanos , Recidiva
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...